Latest / Community Health Media
Dr. Sigrun Hallmeyer & Dr. William Gradishar - SERENA-6 & Early Endocrine Resistance
What if we could detect endocrine resistance before it shows up on scans?
In this CHM Conversations episode, Dr. Sigrun Hallmeyer and Dr. William Gradishar break down the SERENA-6 trial and what it means for the future of HR-positive, HER2-negative metastatic breast cancer.
From early detection of ESR1 mutations using ctDNA to switching therapy before clinical progression, this discussion explores how molecular monitoring is reshaping treatment decisions, extending progression-free survival, and preserving quality of life.
The conversation also dives into real-world implementation, patient…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.